# OnCo record cabazitaxel (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/cabazitaxel/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "cabazitaxel" ;
  schema:name "Cabazitaxel"@en ;
  schema:description "A second taxane that works after docetaxel and beat a second hormone pill head-to-head (CARD)."@en ;
  schema:url <https://onco.cc/drugs/cabazitaxel/> ;
  schema:dateModified "2026-09-06"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Cabazitaxel> ;
  owl:sameAs <http://www.wikidata.org/entity/Q412963> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Cabazitaxel>, <https://www.nice.org.uk/guidance/ta391>, <https://doi.org/10.1200/JCO.2016.72.1076> ;
  onco:status "approved" ;
  onco:modality "Cytotoxic chemotherapy (taxane)" ;
  schema:alternateName "Jevtana" ;
  onco:approval "US 2010: mCRPC after docetaxel" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:companies <https://onco.cc/companies/sanofi/> ;
  onco:terms <https://onco.cc/terms/efflux-pump/>, <https://onco.cc/terms/prostate-crpc-sequencing/>, <https://onco.cc/terms/prostate-uk-drug-approvals/> ;
  onco:trials <https://onco.cc/trials/therap/>, <https://onco.cc/trials/xalute/>, <https://onco.cc/trials/nct07213674/>, <https://onco.cc/trials/nct07611110/>, <https://onco.cc/trials/nct06353386/> .